Lisa M. Prince

Lisa M. Prince

Auto-generated profile, based on publicly available information

Lisa M. Prince

ICF, Reston, VA

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 June 2021 in Food and Chemical Toxicology
Verified
Journal Article
Closed access
MNMaja Diana Neely
Maja Diana Neely
SXShaojun Xie
Shaojun Xie
LPLisa M. Prince
Lisa M. Prince
HKHyunjin Kim
Hyunjin Kim
ATAnke M. Tukker
Anke M. Tukker
ABAaron B. Bowman
Aaron B. Bowman

5 April 2021 in Food and Chemical Toxicology
Verified
Journal Article
Closed access
LPLisa M. Prince
Lisa M. Prince
MNM. Diana Neely
M. Diana Neely
EWEmily B. Warren
Emily B. Warren
MTMorgan G. Thomas
Morgan G. Thomas
MHMadeline R. Henley
Madeline R. Henley
ABAaron B. Bowman
Aaron B. Bowman

29 June 2022 in npj Parkinson's Disease
Verified
Journal Article
Open access
PDF file
HCHolly N. Cukier
Holly N. Cukier
HKHyunjin Kim
Hyunjin Kim
AGAnthony J. Griswold
Anthony J. Griswold
SCSimona G. Codreanu
Simona G. Codreanu
LPLisa M. Prince
Lisa M. Prince
M. Diana NeelyM. Diana Neely
M. Diana Neely
We previously reported on two brothers who carry identical compound heterozygousPRKNmutations yet present with significantly different Parkinson’s Disease (PD) clinical phenotypes. Juvenile cases demonstrate that PD is not necessarily an aging-associated disease. Indeed, evidence for a developmental component to PD pathogenesis is accumulating. Thus, we hypothesized that the presence of additional genetic modifiers, including genetic loci relevant to mesencephalic dopamine neuron development, could potentially contribute to the different clinical manifestations of the two brothers. We differentiated human-induced pluripotent stem cells (hiPSCs) derived from the two brothers into mesencephalic neural precursor cells and early postmitotic dopaminergic neurons and performed wholeexome sequencing and transcriptomic and metabolomic analyses. No significant differences in the expression of canonical dopamine neuron differentiation markers were observed. Yet our transcriptomic analysis revealed a significant downregulation of the expression of three neurodevelopmentally relevant cell adhesion molecules,CNTN6,CNTN4andCHL1, in the cultures of the more severely affected brother. In addition, severalHLAgenes, known to play a role in neurodevelopment, were differentially regulated. The expression ofEN2, a transcription factor crucial for mesencephalic dopamine neuron development, was also differentially regulated. We further identified differences in cellular processes relevant to dopamine metabolism. Lastly, wholeexome sequencing, transcriptomics and metabolomics data all revealed differences in glutathione (GSH) homeostasis, the dysregulation of which has been previously associated with PD. In summary, we identified genetic differences which could potentially, at least partially, contribute to the discordant clinical PD presentation of the two brothers.

15 December 2020 in Food and Chemical Toxicology
Verified
Journal Article
Closed access
BFBeatriz Ferrer
Beatriz Ferrer
LPLisa M. Prince
Lisa M. Prince
TATinkov Alexey
Tinkov Alexey
ASAbel Santamaria
Abel Santamaria
Marcelo FarinaMarcelo Farina
Marcelo Farina
Michael AschnerMichael Aschner
Michael Aschner

1 November 2021 in Food and Chemical Toxicology
Verified
Journal Article
Closed access
RBRekha C. Balachandran
Rekha C. Balachandran
FYFrank Michael Yanko
Frank Michael Yanko
PCPinjing Cheng
Pinjing Cheng
LPLisa M. Prince
Lisa M. Prince
CRChloe N. Rivers
Chloe N. Rivers
ABAaron B. Bowman
Aaron B. Bowman

1 January 2021 in Food and Chemical Toxicology
Verified
Journal Article
Closed access
BFBeatriz Ferrer
Beatriz Ferrer
LPLisa M. Prince
Lisa M. Prince
TATinkov Alexey
Tinkov Alexey
ASAbel Santamaria
Abel Santamaria
ABAaron B. Bowman
Aaron B. Bowman
Michael AschnerMichael Aschner
Michael Aschner